Concerning TRAF6 and NFKB1 and miRNA expression in monocytes and RA development or clinical features, we did not observe differences in genes and miRNA expression between RA patients and healthy controls or about clinical features of RA patients (clinical activity indices, serological parameters, or treatment). This evidence concerns the gene TRAF6 and rheumatoid arthritis.